Chemed Corp Ownership

CHE Stock  USD 563.28  10.41  1.88%   
The market capitalization of Chemed Corp is $8.44 Billion. The majority of Chemed Corp outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Chemed Corp to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Chemed Corp. Please pay attention to any change in the institutional holdings of Chemed Corp as this could imply that something significant has changed or is about to change at the company. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.
 
Shares in Circulation  
First Issued
1985-09-30
Previous Quarter
15.3 M
Current Value
15.1 M
Avarage Shares Outstanding
19.6 M
Quarterly Volatility
2.9 M
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Some institutional investors establish a significant position in stocks such as Chemed Corp in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Chemed Corp, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
The current year's Dividend Paid And Capex Coverage Ratio is expected to grow to 4.32, whereas Dividends Paid is forecasted to decline to about 16.4 M. The current year's Common Stock Shares Outstanding is expected to grow to about 15.9 M. The current year's Net Income Applicable To Common Shares is expected to grow to about 301.4 M.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemed Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
For information on how to trade Chemed Stock refer to our How to Trade Chemed Stock guide.

Chemed Stock Ownership Analysis

About 97.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 2.25. Chemed Corp recorded earning per share (EPS) of 19.79. The entity last dividend was issued on the 18th of November 2024. The firm had 2:1 split on the 12th of May 2005. Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio. Chemed operates under Medical Care Facilities classification in the United States and is traded on New York Stock Exchange. It employs 14137 people. For more info on Chemed Corp please contact Kevin McNamara at 513 762 6690 or go to https://www.chemed.com.
Besides selling stocks to institutional investors, Chemed Corp also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Chemed Corp's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Chemed Corp's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Chemed Corp Quarterly Liabilities And Stockholders Equity

1.77 Billion

Chemed Corp Insider Trades History

Roughly 2.0% of Chemed Corp are currently held by insiders. Unlike Chemed Corp's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Chemed Corp's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Chemed Corp's insider trades
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Chemed Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Chemed Corp is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Chemed Corp backward and forwards among themselves. Chemed Corp's institutional investor refers to the entity that pools money to purchase Chemed Corp's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Jpmorgan Chase & Co2024-06-30
271.3 K
Fmr Inc2024-09-30
238.6 K
Td Global Investment Solutions – Td Epoch2024-06-30
223.1 K
Btim Corp2024-09-30
220.1 K
Massachusetts Financial Services Company2024-09-30
200.7 K
Amvescap Plc.2024-06-30
186.3 K
Dimensional Fund Advisors, Inc.2024-09-30
180.7 K
Northern Trust Corp2024-09-30
174.8 K
Norges Bank2024-06-30
174.7 K
Vanguard Group Inc2024-09-30
1.7 M
Blackrock Inc2024-06-30
1.4 M
Note, although Chemed Corp's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Chemed Corp Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Chemed Corp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Chemed Corp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Chemed Corp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Kevin McNamara over a month ago
Acquisition by Kevin McNamara of 40332 shares of Chemed Corp at 597.7 subject to Rule 16b-3
 
George Walsh over a month ago
Disposition of 400 shares by George Walsh of Chemed Corp at 597.47 subject to Rule 16b-3
 
Nicholas Westfall over two months ago
Disposition of 1713 shares by Nicholas Westfall of Chemed Corp at 569.35 subject to Rule 16b-3
 
George Walsh over three months ago
Disposition of 200 shares by George Walsh of Chemed Corp at 577.95 subject to Rule 16b-3
 
Spencer Lee over three months ago
Disposition of 1016 shares by Spencer Lee of Chemed Corp at 580.48 subject to Rule 16b-3
 
Spencer Lee over three months ago
Disposition of 1016 shares by Spencer Lee of Chemed Corp at 580.48 subject to Rule 16b-3
 
Thomas Hutton over three months ago
Disposition of 4827 shares by Thomas Hutton of Chemed Corp at 576.32 subject to Rule 16b-3
 
Thomas Hutton over three months ago
Disposition of 4827 shares by Thomas Hutton of Chemed Corp at 576.32 subject to Rule 16b-3
 
Kevin McNamara over three months ago
Disposition of 1500 shares by Kevin McNamara of Chemed Corp at 544.17 subject to Rule 16b-3
 
Michael Witzeman over three months ago
Disposition of 2685 shares by Michael Witzeman of Chemed Corp at 582.95 subject to Rule 16b-3
 
Kevin McNamara over six months ago
Acquisition by Kevin McNamara of 1081 shares of Chemed Corp at 586.49 subject to Rule 16b-3
 
Michael Witzeman over six months ago
Acquisition by Michael Witzeman of 942 shares of Chemed Corp subject to Rule 16b-3

Chemed Corp Outstanding Bonds

Chemed Corp issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Chemed Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Chemed bonds can be classified according to their maturity, which is the date when Chemed Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Chemed Corp Corporate Filings

10Q
1st of November 2024
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
ViewVerify
8K
29th of October 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
23rd of October 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
12th of August 2024
Other Reports
ViewVerify

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Chemed Corp is a strong investment it is important to analyze Chemed Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Chemed Corp's future performance. For an informed investment choice regarding Chemed Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemed Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
For information on how to trade Chemed Stock refer to our How to Trade Chemed Stock guide.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemed Corp. If investors know Chemed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemed Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.014
Dividend Share
1.7
Earnings Share
19.79
Revenue Per Share
157.577
Quarterly Revenue Growth
0.074
The market value of Chemed Corp is measured differently than its book value, which is the value of Chemed that is recorded on the company's balance sheet. Investors also form their own opinion of Chemed Corp's value that differs from its market value or its book value, called intrinsic value, which is Chemed Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemed Corp's market value can be influenced by many factors that don't directly affect Chemed Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemed Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemed Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemed Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.